Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A CostBenefit Appraisal of Casting Materials in Trauma Management

A CostBenefit Appraisal of Casting Materials in Trauma Management Since earliest history, splintage materials have been used forimmobilisation of injuries, especially fractures. The use of gypsum inthis domain dates from the eleventh century and remains in common usagetoday. Lighter materials have been produced in an attempt to improveperformance. The authors examined 180 patients comprising 90 upper limband 90 lower limb with 30 in each of the three groups, traditionalgypsum fibreglass and new polypropylene. The gypsum cast remains thecheapest at an average cost of 3.51 per patient compared to7.18 for fibreglass and 7.45 for polypropylene upperlimb. However, the noncost advantages of the new product which wereidentified may make this extra expense worthwhile in selected cases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Management in Medicine Emerald Publishing

A CostBenefit Appraisal of Casting Materials in Trauma Management

Download PDF
8 pages

Loading next page...
 
/lp/emerald-publishing/a-costbenefit-appraisal-of-casting-materials-in-trauma-management-vTksz1BELM

References (3)

Publisher
Emerald Publishing
Copyright
Copyright © Emerald Group Publishing Limited
ISSN
0268-9235
DOI
10.1108/EUM0000000001321
Publisher site
See Article on Publisher Site

Abstract

Since earliest history, splintage materials have been used forimmobilisation of injuries, especially fractures. The use of gypsum inthis domain dates from the eleventh century and remains in common usagetoday. Lighter materials have been produced in an attempt to improveperformance. The authors examined 180 patients comprising 90 upper limband 90 lower limb with 30 in each of the three groups, traditionalgypsum fibreglass and new polypropylene. The gypsum cast remains thecheapest at an average cost of 3.51 per patient compared to7.18 for fibreglass and 7.45 for polypropylene upperlimb. However, the noncost advantages of the new product which wereidentified may make this extra expense worthwhile in selected cases.

Journal

Journal of Management in Medicine – Emerald Publishing

Published: Apr 1, 1991

There are no references for this article.